O-RAN-ALLIANCE
The O-RAN Global PlugFest Fall 2022 was successfully completed in 6 venues across Asia, Europe, and North America, with 106 participating companies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214005850/en/
O-RAN ALLIANCE global PlugFests represent a major platform enabling efficient progress of the O-RAN ecosystem through well-organized testing and integration. O-RAN Global PlugFest Fall 2022 is the second O-RAN PlugFest this year. In combination with the Spring PlugFest, the 2022 O-RAN Global PlugFests span across 9 venues with 156 participants, of which many participated at more than one venue.
“Testing and integration at O-RAN PlugFests show increasing maturity of O-RAN technology in all regions,” said Linsheng Liao, O-RAN TIFG Co-chair and Senior Project Manager of CMRI. “Comparing the PlugFest results year to year, we are pleased to see major progress made by the O-RAN ecosystem in conformance and interoperability tests, as well as more advanced end-to-end and network automation scenarios. O-RAN PlugFests greatly contribute to developing commercially available O-RAN networks.”
O-RAN Global PlugFest Fall 2022 in Asia
PlugFest in Japan, hosted by NTT DOCOMO, KDDI, Rakuten Mobile, SoftBank, YRP and YRP R&D Promotion Committee took place at multiple sites in large metropolitan area. Activities focused on:
- Lab tests and field trials of latency assurance with Near-RT RIC for E2E network slicing
- Conformance, IOT, E2E testing, including Open Fronthaul and security verification
- Field tests of mmW backhaul system using O-RAN Fronthaul
- Multi-vendor vRAN integration
- Near-RT RIC demo with xApp and E2 nodes
- Open source demo realizing vRAN application deployment with OpenStack Tacker
In addition to the hosts, participants included AMD AECG, Anritsu, ComWorth, Dell Technologies, DKK, DZS, Fujitsu, HCL, Keysight Technologies, KYOCERA, NEC, NVIDIA, Red Hat, Spirent, TOYO, VIAVI Solutions and Wind River.
PlugFest in South Korea hosted by LG Uplus focused on:
- 5G O-RAN in-building field trial
- 5G O-RAN Lab validation
- Test scenarios including fronthaul conformance test, E2E test, analysis of fronthaul and midhaul interfaces
- Validation of RIC use case with xApp/rApp and the open interfaces (O1, A1, and E2)
In addition to the hosts, participants included Ciena, DELL Technologies, ETRI, Innowireless, Juniper Networks, Keysight Technologies and Viettel High Technology Industries.
PlugFest in South Korea hosted by SK Telecom focused on:
- Open Fronthaul interface conformance testing for O-DU and O-RU
- O-RAN specified interoperability testing between O-DU and O-RU
- Evaluation of O-RAN based private 5G systems through O-RAN specified E2E tests
- Performance and functional testing in live indoor environments
In addition to the hosts, participants included ETRI, Hewlett Packard Enterprise, HFR, Intel and Keysight Technologies.
O-RAN Global PlugFest Fall 2022 in Europe
Deutsche Telekom, EANTC, EURECOM, Orange, TIM, Vodafone and BT have teamed up together with Telecom Infra Project (TIP) to host the Joint European O-RAN & TIP PlugFest Fall 2022. The PlugFest was hosted in four European labs, namely EURECOM in Sophia Antipolis, i14y Lab in Berlin, Orange Lab in Paris and TIM Innovation Lab in Torino.
The joint PlugFest has demonstrated complementarities and synergies between O-RAN and TIP as well as between the labs.
Test scenarios focused on:
- Conformance testing of Open Fronthaul interface of O-RU and O-DU
- End-to-end multi-vendor integration with functional and performance testing
- xApps/rApps integration with Near/Non-RT RICs and xApps/rApps functional verification
- O-Cloud platform performance testing
In addition to the hosts, participants included Aarna Networks, Accelleran, ADVA Optical Networking, Analog Devices, Anritsu, Aspire Technology, Azcom Technology, Calnex Solutions, Capgemini Engineering, Dell Technologies, DZS, Fujitsu, Hewlett Packard Enterprise, highstreet technologies, JMA Wireless, Juniper Networks, Keysight Technologies, Mavenir, Microamp Solutions, MTI, NEC, Net AI, Nokia, Open Networking Foundation, Radisys, Red Hat, Rimedo Labs, Rohde & Schwarz, SIAE MICROELETTRONICA, SOLiD, Spirent, VIAVI Solutions, VMware and VoerEir.
O-RAN Global PlugFest Fall 2022 in North America
PlugFest in North America hosted by CableLabs at the Kyrio OTIC Lab focused on:
- Multi-vendor O-RAN end-to-end system under test, based on the O-RAN E2E test specification, demonstrating cell capacity for signaling and user-plane traffic load. Moreover, the Fronthaul delay impact on user peak throughput was measured using Fronthaul impairment emulators.
- Demonstration of O-CU interoperability, based on the O-RAN IOT test specifications, verified traffic scenarios across emulated F1 and Xn interfaces, as well as the open F1 and Xn protocol implementation. In addition, the O-CU demonstrated successful interoperability for F1AP and XnAP global, elementary, and mobility procedures.
- Near-RT RIC testing for conformance to the O-RAN E2 interface specification (E2AP, E2 SM, E2 SM RC, and E2 SM KPM procedures) were verified following the E2 test specification. Moreover, a QoS xApp was integrated and tested.
In addition to the hosts, participants included Calnex Solutions, Capgemini Engineering, Lumentum Holdings, Radisys Networks, Sunwave Communications, VIAVI Solutions and Xena Networks.
PocFest in North America hosted by UNH-IOL, hosted by AT&T and DISH, took place in four labs:
- University of New Hampshire InterOperability Lab
- TIP Community Lab at Meta, Menlo Park CA
- POWDER Lab and NSF PAWR SITE with the University of Utah
- COSMOS Lab and NSF PAWR SITE with the Rutgers University, Columbia University, NYU Wireless
Activities focused on testing of conformance and performance of O-RU devices, measurements of energy saving and efficiency, integration of AI/ML for resource pooling and slicing, testing of RIC, xApps, SMO, and end-to-end interoperability testing.
In addition to the hosts, participants included AMD, Anritsu, Calnex, DZS, Fujitsu, HCL, Intel, Keysight Technologies, NEC, Radisys, Rohde & Schwarz, VIAVI Solutions, VVDN, VMware, Vodafone, Wind River and Xena.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 330 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information, please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005850/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press release
Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable
GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press release
Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus
Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press release
Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom